[
  {
    "id": "0b0402437fa821c2",
    "title": "What obesity drugmakers see next in the market: More pills, easier access and drug combinations",
    "link": "https://www.cnbc.com/2026/01/23/weight-loss-glp-1-drugs-next-steps-for-eli-lilly-novo-nordisk-pfizer.html",
    "summary": "CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.",
    "body": null,
    "image": null,
    "pubDate": "2026-01-23T12:50:24.000Z",
    "source": {
      "name": "CNBC â€” Markets",
      "homepage": "https://www.cnbc.com/id/100003114/device/rss/rss.html"
    },
    "lang": "en",
    "category": "health",
    "region": "global"
  }
]